Victor Kotsev is a reporter-at-large. He does all things business, technology, and international politics, with a special focus on health and biotech. He has spent most of the 2010s covering the Balkans and the Middle East for the likes of USA Today, Globe and Mail, and Fast Company, primarily out of Istanbul.

Articles by Victor Kotsev

Agomab bags $114 million in thriving regenerative medicine sector

Expert Advice 2 May 2022

Chief Business Officers: Shedding Light on Biotech’s Dealmakers

Microbiome Space in Spotlight as Microbiotica Sets Funding Record

Reforms of EU Clinical Trial Regulations Bring Cautious Optimism

Expert Advice 24 Jan 2022

Transitioning from Academia to Chief Scientific Officer in the Biotech Industry

Despite New Approvals, Covid-19 Treatments Lag Behind Vaccines


Evotec IPO Hints At Stabilizing Investor Interest In Biotech Stocks

Expert Advice 1 Nov 2021

“The Board of Directors Should Let the CEO Run the Company”

Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial

Third-Generation DNA Sequencing Shines with Oxford Nanopore’s IPO

Longevity Foundation to Fund Geroscience Research with €860M

Non-Viral Gene Therapies Get €51M Boost, Though Challenges Remain